|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Coordes A, Lenz K, Qian X, Lenarz M,
Kaufmann AM and Albers AE: Meta-analysis of survival in patients
with HNSCC discriminates risk depending on combined HPV and p16
status. Eur Arch Otorhinolaryngol. 273:2157–2169. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tinhofer I, Jöhrens K, Keilholz U,
Kaufmann A, Lehmann A, Weichert W, Stenzinger A, Stromberger C,
Klinghammer K, Becker ET, et al: Contribution of human papilloma
virus to the incidence of squamous cell carcinoma of the head and
neck in a European population with high smoking prevalence. Eur J
Cancer. 51:514–521. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Posner MR, Hershock DM, Blajman CR,
Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM,
Cullen K, Ervin TJ, et al: Cisplatin and fluorouracil alone or with
docetaxel in head and neck cancer. N Engl J Med. 357:1705–1715.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vermorken JB, Remenar E, van Herpen C,
Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss
JH, et al: Cisplatin, fluorouracil, and docetaxel in unresectable
head and neck cancer. N Engl J Med. 357:1695–1704. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartsch V: Assault on the mitotic spindle.
The action mechanism of taxane. Pharm Unserer Zeit. 34:104–108.
2005.(In German). View Article : Google Scholar
|
|
8
|
Qian X, Ma C, Hoffmann TK, Kaufmann AM and
Albers AE: Taxane-cisplatin-fluorouracil as induction chemotherapy
for advanced head and neck cancer: A meta-analysis of the 5-year
efficacy and safety. Springerplus. 4:2082015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Blanchard P, Baujat B, Holostenco V,
Bourredjem A, Baey C, Bourhis J and Pignon JP; MACH-CH
Collaborative group, : Meta-analysis of chemotherapy in head and
neck cancer (MACH-NC): A comprehensive analysis by tumour site.
Radiother Oncol. 100:33–40. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma J, Liu Y, Yang X, Zhang CP, Zhang ZY
and Zhong LP: Induction chemotherapy in patients with resectable
head and neck squamous cell carcinoma: A meta-analysis. World J
Surg Oncol. 11:672013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Al-Mamgani A, van Rooij P, Verduijn GM,
Mehilal R, Kerrebijn JD and Levendag PC: The impact of treatment
modality and radiation technique on outcomes and toxicity of
patients with locally advanced oropharyngeal cancer. Laryngoscope.
123:386–393. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cooper JS, Zhang Q, Pajak TF, Forastiere
AA, Jacobs J, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, et
al: Long-term follow-up of the RTOG 9501/intergroup phase III
trial: Postoperative concurrent radiation therapy and chemotherapy
in high-risk squamous cell carcinoma of the head and neck. Int J
Radiat Oncol Biol Phys. 84:1198–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Billan S, Kaidar-Person O, Atrash F,
Doweck I, Haim N, Kuten A and Ronen O: Toxicity of induction
chemotherapy with docetaxel, cisplatin and 5-fluorouracil for
advanced head and neck cancer. Isr Med Assoc J. 15:231–235.
2013.PubMed/NCBI
|
|
14
|
Lorch JH, Goloubeva O, Haddad RI, Cullen
K, Sarlis N, Tishler R, Tan M, Fasciano J, Sammartino DE and Posner
MR; TAX 324 Study Group, : Induction chemotherapy with cisplatin
and fluorouracil alone or in combination with docetaxel in locally
advanced squamous-cell cancer of the head and neck: Long-term
results of the TAX 324 randomised phase 3 trial. Lancet Oncol.
12:153–159. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Haddad R, O'Neill A, Rabinowits G, Tishler
R, Khuri F, Adkins D, Clark J, Sarlis N, Lorch J, Beitler JJ, et
al: Induction chemotherapy followed by concurrent chemoradiotherapy
(sequential chemoradiotherapy) versus concurrent chemoradiotherapy
alone in locally advanced head and neck cancer (PARADIGM): A
randomised phase 3 trial. Lancet Oncol. 14:257–264. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhong LP, Zhang CP, Ren GX, Guo W, William
WN Jr, Sun J, Zhu HG, Tu WY, Li J, Cai YL, et al: Randomized phase
III trial of induction chemotherapy with docetaxel, cisplatin, and
fluorouracil followed by surgery versus up-front surgery in locally
advanced resectable oral squamous cell carcinoma. J Clin Oncol.
31:744–751. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Paccagnella A, Ghi MG, Loreggian L,
Buffoli A, Koussis H, Mione CA, Bonetti A, Campostrini F, Gardani
G, Ardizzoia A, et al: Concomitant chemoradiotherapy versus
induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by
concomitant chemoradiotherapy in locally advanced head and neck
cancer: A phase II randomized study. Ann Oncol. 21:1515–1522. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin JT, Lai GM, Chang TH, Liu MT, Bi CP,
Wang JW and Chen MK: Chemotherapy with modified docetaxel,
cisplatin, and 5-fluorouracil in patients with metastatic head and
neck cancer. Adv Ther. 29:71–77. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
van Herpen CM, Mauer ME, Mesia R, Degardin
M, Jelic S, Coens C, Betka J, Bernier J, Remenar E, Stewart JS, et
al: Short-term health-related quality of life and symptom control
with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF),
5-fluorouracil (PF) for induction in unresectable locoregionally
advanced head and neck cancer patients (EORTC 24971/TAX 323). Br J
Cancer. 103:1173–1181. 2010. View Article : Google Scholar : PubMed/NCBI
|
